Search

Your search keyword '"Kuulasmaa, T."' showing total 163 results

Search Constraints

Start Over You searched for: Author "Kuulasmaa, T." Remove constraint Author: "Kuulasmaa, T."
163 results on '"Kuulasmaa, T."'

Search Results

1. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

3. New insights into the genetic etiology of Alzheimer's disease and related dementias

4. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

5. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

6. New insights into the genetic etiology of Alzheimer's disease and related dementias

8. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

9. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

10. Novel biomarkers associated with incident heart failure in 10 106 Finnish men

11. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

12. A novel genetic marker for the C9orf72 repeat expansion in the Finnish population

13. The trans-ancestral genomic architecture of glycemic traits

14. The trans-ancestral genomic architecture of glycemic traits

16. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study

18. A reference map of potential determinants for the human serum metabolome

23. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy

25. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

27. Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.

28. Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study

30. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass.

31. Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls

32. Detection of novel gene variants associated with congenital hypothyroidism in a Finnish patient cohort

33. y New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk

34. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

36. A link between GIP and osteopontin in adipose tissue and insulin resistance

37. SFRS10-A Splicing Factor Gene Reduced in Human Obesity? Response

38. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

39. A novel surrogate index for hepatic insulin resistance

40. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

41. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

44. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

45. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study

50. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-{alpha} gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM Trial.

Catalog

Books, media, physical & digital resources